Medicine & TechnologyMedicine regulators greenlight the first CRISPR therapy, Casgevy, for genetic blood disorders. Explore its approval, mechanism, and details in this article.
The world's first gene therapy for sickle cell disease has now been approved in the UK and can be applied to patients of sickle cell disease who are at least 12 years old and meet certain conditions. Read to learn more.
Experts reveal how high the cost of living with sickle cell disease is. Read more about the financial toll SCD patients experience and how absurd their payments for out-of-pocket medical expenses are.